Literature DB >> 16458787

Basic mapping principles for visualizing cancer data using Geographic Information Systems (GIS).

Cynthia A Brewer1.   

Abstract

Maps and other data graphics may play a role in generating ideas and hypotheses at the beginning of a project. They are useful as part of analyses for evaluating model results and then at the end of a project when researchers present their results and conclusions to varied audiences, such as their local research group, decision makers, or a concerned public. Cancer researchers are gaining skill with geographic information system (GIS) mapping as one of their many tools and are broadening the symbolization approaches they use for investigating and illustrating their data. A single map is one of many possible representations of the data, so making multiple maps is often part of a complete mapping effort. Symbol types, color choices, and data classing each affect the information revealed by a map and are best tailored to the specific characteristics of data. Related data can be examined in series with coordinated classing and can also be compared using multivariate symbols that build on the basic rules of symbol design. Informative legend wording and setting suitable map projections are also basic to skilled mapmaking.

Entities:  

Mesh:

Year:  2006        PMID: 16458787     DOI: 10.1016/j.amepre.2005.09.007

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  32 in total

1.  ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.

Authors:  Claudia Capparelli; Timothy J Purwin; Shea A Heilman; Inna Chervoneva; Peter A McCue; Adam C Berger; Michael A Davies; Jeffrey E Gershenwald; Clemens Krepler; Andrew E Aplin
Journal:  Cancer Res       Date:  2018-08-16       Impact factor: 12.701

2.  The influence of mapped hazards on risk beliefs: a proximity-based modeling approach.

Authors:  Dolores J Severtson; James E Burt
Journal:  Risk Anal       Date:  2011-11-06       Impact factor: 4.000

3.  A heuristic multi-criteria classification approach incorporating data quality information for choropleth mapping.

Authors:  Min Sun; David Wong; Barry Kronenfeld
Journal:  Cartogr Geogr Inf Sci       Date:  2016-02-25

Review 4.  GIScience and cancer: State of the art and trends for cancer surveillance and epidemiology.

Authors:  Liora Sahar; Stephanie L Foster; Recinda L Sherman; Kevin A Henry; Daniel W Goldberg; David G Stinchcomb; Joseph E Bauer
Journal:  Cancer       Date:  2019-05-30       Impact factor: 6.860

5.  Use of density-equalizing cartograms to visualize trends and disparities in state-specific prevalence of obesity: 1996-2006.

Authors:  Brian Houle; James Holt; Cathleen Gillespie; David S Freedman; Michele Reyes
Journal:  Am J Public Health       Date:  2008-12-04       Impact factor: 9.308

6.  Feasibility and utility of mapping disease risk at the neighbourhood level within a Canadian public health unit: an ecological study.

Authors:  Eric J Holowaty; Todd A Norwood; Susitha Wanigaratne; Juanjo J Abellan; Linda Beale
Journal:  Int J Health Geogr       Date:  2010-05-10       Impact factor: 3.918

7.  Comprehensive analysis of LC/MS data using pseudocolor plots.

Authors:  Christopher A Crutchfield; Matthew T Olson; Evgenia Gourgari; Maria Nesterova; Constantine A Stratakis; Alfred L Yergey
Journal:  J Am Soc Mass Spectrom       Date:  2013-01-03       Impact factor: 3.109

8.  A critical assessment of geographic clusters of breast and lung cancer incidences among residents living near the Tittabawassee and Saginaw Rivers, Michigan, USA.

Authors:  Olga A Guajardo; Tonny J Oyana
Journal:  J Environ Public Health       Date:  2009-11-25

9.  Choropleth map design for cancer incidence, part 2.

Authors:  Thomas B Richards; Zahava Berkowitz; Cheryll C Thomas; Stephanie Lee Foster; Annette Gardner; Jessica Blythe King; Karen Ledford; Janet Royalty
Journal:  Prev Chronic Dis       Date:  2009-12-15       Impact factor: 2.830

10.  Choropleth map design for cancer incidence, part 1.

Authors:  Thomas B Richards; Zahava Berkowitz; Cheryll C Thomas; Stephanie Lee Foster; Annette Gardner; Jessica Blythe King; Karen Ledford; Janet Royalty
Journal:  Prev Chronic Dis       Date:  2009-12-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.